Mind Medicine (MindMed) Statistics
Share Statistics
Mind Medicine (MindMed) has 73.33M shares outstanding. The number of shares has increased by 102.92% in one year.
| Shares Outstanding | 73.33M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 15.4% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 70.94M |
| Failed to Deliver (FTD) Shares | 10.88K |
| FTD / Avg. Volume | 0.95% |
Short Selling Information
The latest short interest is 9.98M, so 13.61% of the outstanding shares have been sold short.
| Short Interest | 9.98M |
| Short % of Shares Out | 13.61% |
| Short % of Float | 14.07% |
| Short Ratio (days to cover) | 16.07 |
Valuation Ratios
The PE ratio is -1.5 and the forward PE ratio is -5.98.
| PE Ratio | -1.5 |
| Forward PE | -5.98 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 1.83 |
| P/FCF Ratio | -2.23 |
| PEG Ratio | n/a |
Enterprise Valuation
Mind Medicine (MindMed) Inc. has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 3.22, with a Debt / Equity ratio of 0.18.
| Current Ratio | 3.22 |
| Quick Ratio | 3.22 |
| Debt / Equity | 0.18 |
| Total Debt / Capitalization | 15.31 |
| Cash Flow / Debt | -4.56 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -1.23% and return on capital (ROIC) is -101.74%.
| Return on Equity (ROE) | -1.23% |
| Return on Assets (ROA) | -0.77% |
| Return on Capital (ROIC) | -101.74% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -1.68M |
| Employee Count | 57 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 112.84% in the last 52 weeks. The beta is 2.33, so Mind Medicine (MindMed) 's price volatility has been higher than the market average.
| Beta | 2.33 |
| 52-Week Price Change | 112.84% |
| 50-Day Moving Average | 6.86 |
| 200-Day Moving Average | 7.65 |
| Relative Strength Index (RSI) | 45.7 |
| Average Volume (20 Days) | 1.14M |
Income Statement
In the last 12 months, Mind Medicine (MindMed) had revenue of $0 and earned -$95.73M in profits. Earnings per share was $-2.44.
| Revenue | 0 |
| Gross Profit | -3.16M |
| Operating Income | -93.87M |
| Net Income | -95.73M |
| EBITDA | -92.57M |
| EBIT | - |
| Earnings Per Share (EPS) | -2.44 |
Balance Sheet
The company has $99.70M in cash and $14.13M in debt, giving a net cash position of $85.58M.
| Cash & Cash Equivalents | 99.70M |
| Total Debt | 14.13M |
| Net Cash | 85.58M |
| Retained Earnings | -290.20M |
| Total Assets | 319.77M |
| Working Capital | 266.09M |
Cash Flow
In the last 12 months, operating cash flow was -$64.36M and capital expenditures $0, giving a free cash flow of -$64.36M.
| Operating Cash Flow | -64.36M |
| Capital Expenditures | 0 |
| Free Cash Flow | -64.36M |
| FCF Per Share | -1.64 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
MNMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -34.22% |
| FCF Yield | -12.3% |
Analyst Forecast
The average price target for MNMD is $21, which is 194.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $21 |
| Price Target Difference | 194.5% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
Stock Splits
The last stock split was on Aug 29, 2022. It was a backward split with a ratio of 1:15.
| Last Split Date | Aug 29, 2022 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | 3.67 |
| Piotroski F-Score | 3 |